Davion Healthcare PLC SEC filings DAVI
Davion Healthcare PLC has 31 filings in SEC EDGAR's recent list, going back to Aug 4, 2025. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 29, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 29, 2026 | Oct 29, 2026 |
| 6-K | Current report (foreign issuer) | Oct 27, 2026 | Oct 26, 2026 |
| CERT | Filing | Oct 21, 2026 | — |
| 424B3 | Prospectus | Oct 20, 2026 | — |
| 6-K | Current report (foreign issuer) | Oct 20, 2026 | Oct 20, 2026 |
| 424B3 | Prospectus | Oct 13, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 15, 2026 | Sep 15, 2026 |
| D | Filing | Sep 8, 2026 | — |
| POS AM | Filing | Sep 2, 2026 | — |
| POS AM | Post effective amendment no. 6 | Aug 17, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 11, 2026 | — |
| 20-F/A | Amended annual report (foreign issuer) | May 6, 2026 | Dec 31, 2025 |
| POS AM | Post-effective amendment #5 | May 1, 2026 | — |
| 20-F | Annual report (foreign issuer) | Apr 30, 2026 | Dec 31, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Apr 17, 2026 | — |
| 3 | Initial insider ownership | Apr 17, 2026 | Mar 18, 2026 |
| POS AM | Amendment no. 4 | Apr 6, 2026 | — |
| POS AM | Post effective amendment no. 3 | Mar 4, 2026 | — |
| POS AM | Pos am no. 2 | Feb 4, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 5, 2026 | Jan 5, 2026 |
| POS AM | Amendment no 1 | Dec 9, 2025 | — |
| AW | Form aw | Dec 8, 2025 | — |
| F-1/A | Amendment no. 3 to form f-1 | Dec 5, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 2, 2025 | Dec 2, 2025 |
| 8-A12B | Form 8-a12b | Nov 28, 2025 | — |
| F-1/A | Amendment no. 2 to form f-1 | Nov 7, 2025 | — |
| CORRESP | Letter to the SEC | Oct 20, 2025 | — |
| CORRESP | Letter to the SEC | Sep 26, 2025 | — |
| F-1/A | Amendment to f-1 | Sep 26, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 1, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Aug 4, 2025 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- DAVI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cyprus
- Headquarters
- Clonakilty
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2039072
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.